Jens Watzlawik
Affiliations: | 2015- | Department of Neuroscience | Mayo Clinic Florida |
Google:
"Jens Watzlawik"Mean distance: 19.68 (cluster 28) | S | N | B | C | P |
BETA: Related publications
See more...
Publications
|
You can help our author matching system! If you notice any publications incorrectly attributed to this author, please sign in and mark matches as correct or incorrect. |
| Watzlawik JO, Fiesel FC, Fiorino G, et al. (2023) Basal activity of PINK1 and PRKN in cell models and rodent brain. Autophagy. 1-12 |
| Hou X, Heckman MG, Fiesel FC, et al. (2023) Genome-wide association study identifies and variants as mitophagy modifiers in Lewy body disease. Medrxiv : the Preprint Server For Health Sciences |
| Watzlawik JO, Hou X, Truban D, et al. (2020) Sensitive ELISA-based detection method for the mitophagy marker p-S65-Ub in human cells, autopsy brain, and blood samples. Autophagy. 1-16 |
| Hou X, Watzlawik JO, Cook C, et al. (2020) Mitophagy alterations in Alzheimer's disease are associated with granulovacuolar degeneration and early tau pathology. Alzheimer's & Dementia : the Journal of the Alzheimer's Association |
| Singh Angom R, Wang Y, Wang E, et al. (2018) VEGF receptor-1 modulates amyloid β 1-42 oligomer-induced senescence in brain endothelial cells. Faseb Journal : Official Publication of the Federation of American Societies For Experimental Biology. fj201802003R |
| Allen M, Wang X, Burgess JD, et al. (2017) Conserved brain myelination networks are altered in Alzheimer's and other neurodegenerative diseases. Alzheimer's & Dementia : the Journal of the Alzheimer's Association |
| Allen M, Lincoln SJ, Corda M, et al. (2017) ABCA7 loss-of-function variants, expression, and neurologic disease risk. Neurology. Genetics. 3: e126 |
| Watzlawik JO, Wootla B, Rodriguez M. (2016) Tryptophan Catabolites and Their Impact on Multiple Sclerosis Progression. Current Pharmaceutical Design. 22: 1049-59 |
| Watzlawik JO, Wootla B, Rodriguez M. (2015) Tryptophan Metabolites and Their Impact on Multiple Sclerosis Progression. Current Pharmaceutical Design |
| Wootla B, Watzlawik JO, Warrington AE, et al. (2015) Naturally Occurring Monoclonal Antibodies and Their Therapeutic Potential for Neurologic Diseases. Jama Neurology |